Publications by authors named "Ian Peake"

Claim this Profile
S
Sonographic findings of complete tubal abortion.
David M Sherer, Marae Thompson, Mayanna T Olsen, Ian J Peake, Mila Kheyman

Radiol Case Rep· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS.
Maria Teresa Pagliari, Ulrich Budde, Luciano Baronciani, Peyman Eshghi, Minoo Ahmadinejad, Ian Peake

J Thromb Haemost· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS-IPS study.
Maria Teresa Pagliari, Frits R Rosendaal, Minoo Ahmadinejad, Zahra Badiee, Mohammad-Reza Baghaipour, Ian Peake

J Thromb Haemost· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS.
Luciano Baronciani, Ian Peake, Reinhard Schneppenheim, Anne Goodeve, Minoo Ahmadinejad

Blood Adv· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease: Results from 3WINTERS-IPS, an international and collaborative cross-sectional study.
Alberto Tosetto, Zahra Badiee, Mohammad-Reza Baghaipour, Luciano Baronciani, Javier Battle, Ian Peake

J Thromb Haemost· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of large in-frame von Willebrand factor deletions highlights differing pathogenic mechanisms.
Ashley Cartwright, Simon J Webster, Annika de Jong, Richard J Dirven, Lisa D S Bloomer, Ian R Peake

Blood Adv· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The common single nucleotide variants c.2365A>G and c.2385T>C modify VWF biosynthesis and clearance.
Ahmad H Mufti, Kenichi Ogiwara, Laura L Swystun, Jeroen C J Eikenboom, Ulrich Budde, Ian R Peake

Blood Adv· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States.
Veronica H Flood, Pamela A Christopherson, Joan Cox Gill, Kenneth D Friedman, Sandra L Haberichter, Ian R Peake

Blood· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and characterisation of mutations associated with von Willebrand disease in a Turkish patient cohort.
Daniel J Hampshire, Adel M Abuzenadah, Ashley Cartwright, Nawal S Al-Shammari, Rachael E Coyle, Ian R Peake

Thromb Haemost· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease.
Jeroen Eikenboom, Augusto B Federici, Richard J Dirven, Giancarlo Castaman, Francesco Rodeghiero, Ian Peake

Blood· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymorphic variation within the VWF gene contributes to the failure to detect mutations in patients historically diagnosed with type 1 von Willebrand disease from the MCMDM-1VWD cohort.
Daniel J Hampshire, George J Burghel, Jenny Goudemand, Laura C S Bouvet, Jeroen C J Eikenboom, Ian R Peake

Haematologica· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of bleeding history, von Willebrand factor and PFA-100(®) on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWD.
Giancarlo Castaman, Alberto Tosetto, Anne Goodeve, Augusto B Federici, Stefan Lethagen, Ian Peake

Br J Haematol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of nanoscale roughness of titanium thin film surfaces on bacterial retention.
Elena P Ivanova, Vi Khanh Truong, James Y Wang, Christopher C Berndt, Robert T Jones, Ian Peake

Langmuir· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and characterization of a novel P2Y 12 variant in a patient diagnosed with type 1 von Willebrand disease in the European MCMDM-1VWD study.
Martina E Daly, Ban B Dawood, William A Lester, Ian R Peake, Francesco Rodeghiero

Blood· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD).
Sandra L Haberichter, Giancarlo Castaman, Ulrich Budde, Ian Peake, Anne Goodeve

Blood· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD.
Giancarlo Castaman, Stefan Lethagen, Augusto B Federici, Alberto Tosetto, Anne Goodeve, Ian Peake

Blood· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational analysis of the von Willebrand factor gene in type 1 von Willebrand disease using conformation sensitive gel electrophoresis: a comparison of fluorescent and manual techniques.
Mohammad Hashemi Soteh, Ian R Peake, Luke Marsden, John Anson, Javier Batlle

Haematologica· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD).
Anne Goodeve, Jeroen Eikenboom, Giancarlo Castaman, Francesco Rodeghiero, Augusto B Federici, Ian Peake

Blood· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of the human protein S gene promoter by liver enriched transcription factors.
Adrian J Hall, Ian R Peake, Peter R Winship

Br J Haematol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An association of candidate gene haplotypes and bleeding severity in von Willebrand disease (VWD) type 1 pedigrees.
Thomas J Kunicki, Augusto B Federici, Daniel R Salomon, James A Koziol, Steven R Head, Ian R Peake

Blood· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
c-FMS mutational analysis in acute myeloid leukaemia.
Faisel M Abu-Duhier, Anne C Goodeve, Giu A Wilson, Ian R Peake, John T Reilly

Br J Haematol· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of intracellular storage and regulated secretion of 3 von Willebrand disease-causing variants of von Willebrand factor.
Grégoire Michaux, Lindsay J Hewlett, Sarah L Messenger, Anne C Goodeve, Ian R Peake

Blood· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias.
Rory S Care, Peter J M Valk, Anne C Goodeve, Faisel M Abu-Duhier, Wendy M C Geertsma-Kleinekoort, Ian R Peake

Br J Haematol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational analysis of class III receptor tyrosine kinases (C-KIT, C-FMS, FLT3) in idiopathic myelofibrosis.
Faisel M Abu-Duhier, Anne C Goodeve, Rory S Care, Mamdooh Gari, Gill A Wilson, Ian R Peake

Br J Haematol· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The molecular basis of hemophilia A: genotype-phenotype relationships and inhibitor development.
Anne C Goodeve, Ian R Peake

Semin Thromb Hemost· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis